Stay updated on CP-690,550 in RA Patients with Inadequate TNF Response Clinical Trial

Sign up to get notified when there's something new on the CP-690,550 in RA Patients with Inadequate TNF Response Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CP-690,550 in RA Patients with Inadequate TNF Response Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:43:25.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a study testing the safety and efficacy of CP-690,550 in rheumatoid arthritis patients with inadequate response to TNF inhibitors.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:19.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that adults with moderate to severe rheumatoid arthritis on a stable dose of methotrexate who have an inadequate response to TNF inhibitors are eligible. Additionally, it now provides general information about clinical research and examples of eligibility criteria.
    Difference
    9%
    Check dated 2024-05-22T21:37:17.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:44:55.000Z thumbnail image

Stay in the know with updates to CP-690,550 in RA Patients with Inadequate TNF Response Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CP-690,550 in RA Patients with Inadequate TNF Response Clinical Trial page.